Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -30.23% is in line with its 5-year average of -29.40%, near the high end of its 5-year range (-113.99%–-4.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.16% above its 12-month average of -60.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -30.23%.
RETURN ON INVESTED CAPITAL (ROIC)
-30.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-60.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-25.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.16%
CURRENT VS 3Y AVG
-16.99%
CURRENT VS 5Y AVG
-2.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 652 covered companies
CURRENT VS SECTOR MEDIAN
+10.07%
vs the sector median at left
Precision BioSciences, Inc.
Market Cap
$174.62M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-60.66%
3Y Avg
-25.84%
5Y Avg
-29.40%
Market Cap
$173.41M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$173.14M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$176.26M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$179.06M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$169.21M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$180.10M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$166.35M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
Market Cap
$182.67M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-7.29%
3Y Avg
-11.96%
5Y Avg
-13.56%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $174.62M | -30.23% | -60.66% | -25.84% | -29.40% |
| MediWound Ltd. (MDWD)vs › | $173.41M | -58.55% | -41.33% | -32.67% | -48.97% |
| Nkarta, Inc. (NKTX)vs › | $173.14M | -42.11% | -29.16% | -30.37% | -28.38% |
| Cue Biopharma, Inc. (CUE)vs › | $176.26M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.06M | -46.59% | -39.23% | -33.74% | -53.74% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | -8.34% | 4.10% | 3.63% | 7.54% |
| Journey Medical Corporation (DERM)vs › | $180.10M | -5.22% | -22.12% | -29.09% | -27.39% |
| OptimizeRx Corp. (OPRX)vs › | $166.35M | 4.92% | -1.65% | -7.20% | -5.46% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.67M | -3.21% | -7.29% | -11.96% | -13.56% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -135.38% | -110.80% | -91.23% | -65.73% |
ROIC
-30.2%
ROE
-116.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -30.23% |
| 2026-03-31 | -28.73% |
| 2025-12-31 | -35.84% |
| 2025-09-30 | -113.99% |
| 2025-06-30 | -94.49% |
| 2025-03-31 | -39.36% |
| 2024-12-31 | -21.55% |
| 2024-09-30 | -11.47% |
| 2024-06-30 | -4.70% |
| 2024-03-31 | -19.88% |
| 2023-12-31 | -33.08% |
| 2023-09-30 | -30.09% |
| 2023-06-30 | -29.31% |
| 2023-03-31 | -43.66% |
| 2022-12-31 | -46.91% |
| 2022-09-30 | -48.61% |
| 2022-06-30 | -40.80% |
| 2022-03-31 | -31.53% |
| 2021-12-31 | -22.45% |
| 2021-09-30 | -16.63% |
| 2021-06-30 | -23.76% |
| 2021-03-31 | -50.91% |
| 2020-12-31 | -102.33% |
| 2020-09-30 | -85.40% |
| 2020-06-30 | -68.66% |
| 2020-03-31 | -49.99% |
| 2019-12-31 | -41.86% |
| 2019-09-30 | -34.43% |
| 2019-06-30 | -27.30% |
| 2019-03-31 | -39.34% |
| 2018-12-31 | -38.48% |
